CC BY 4.0 · Aorta (Stamford) 2023; 11(05): 1-18
DOI: 10.1055/s-0044-1787941
IMAD 2024 Meeting Abstracts

Unexplained Finding: More than Halved Aneurysmal Growth Rates in DANCAVAS Trial Compared to the VIVA Trial

Joachim Sejr Skovbo Kristensen
1   Department of Cardiac, Thoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark
2   Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark
,
Marie Dahl
2   Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark
3   Department of Vascular Surgery, Vascular Research Unit, Viborg Regional Hospital, Viborg, Denmark
4   Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
,
Katrine Lawaetz Larsen
1   Department of Cardiac, Thoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark
,
Axel Cosmus Pyndt Diederichsen
5   Department of Cardiology, Odense University Hospital, Odense, Denmark
,
Jes Sanddal Lindholt
1   Department of Cardiac, Thoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark
2   Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
 

Keywords

Abdominal aortic aneurysm - growth rate - progression rate - medication - smoking - diabetes mellitus


Publikationsverlauf

Artikel online veröffentlicht:
11. Juni 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Grøndal N, Søgaard R, Lindholt JS. Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65-74 years from a population screening study (VIVA trial). Br J Surg 2015;102(8):902–906
    PubMed
  • 2 Lindholt JS, Søgaard R, Rasmussen LM, et al. Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial. N Engl J Med 2022;387(15):1385–1394
    PubMed
  • 3 Obel LM, Diederichsen AC, Steffensen FH, et al. Population-Based Risk Factors for Ascending, Arch, Descending, and Abdominal Aortic Dilations for 60-74-Year-Old Individuals. J Am Coll Cardiol 2021;78(3):201–211
    PubMed
  • 4 Sweeting MJ, Thompson SG, Brown LC, Powell JT; RESCAN collaborators. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012;99(5):655–665
    PubMed